
Matthew Mossanen MD
Assistant Professor of Surgery, Harvard Medical School, Brigham and Women's Hospital, Division of Urology, Boston, MassachusettsRecent Contributions to PracticeUpdate:
- 2020 Top Stories in Bladder Cancer: Nadofaragene Firadenovec Emerges as a New Treatment Option for BCG-Unresponsive Disease
- The Impact of Obesity on the Outcomes After Radical Cystectomy
- BCG Shortage and Changing Treatment Patterns for Non-Muscle-Invasive Bladder Cancer
- Renorrhaphy After Partial Nephrectomy: Considerations and Planning
- Renorrhaphy After Partial Nephrectomy: Technique
- Renal Masses in a Functionally Solitary Kidney: Surgical Considerations
- Renal Masses in a Functionally Solitary Kidney: Next Steps
- Short-Term, Intensive Chemoresection vs Standard Adjuvant Intravesical Instillations in Non–Muscle-Invasive Bladder Cancer
- Genitourinary Tumor Board: Bladder Cancer Diagnosis
- Upper Tract Urothelial Cell Carcinoma: Part 1